Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -293,905 | -657,939 | -475,690 | -307,077 | 203,408 |
| Depreciation Amortization | 9,043 | 29,054 | 21,832 | 13,485 | 6,765 |
| Accounts receivable | 18,430 | 249,166 | 171,325 | 112,845 | -56,016 |
| Other Working Capital | -80,616 | -361,150 | -319,991 | -188,531 | -332,464 |
| Other Operating Activity | 21,455 | 324,932 | 304,403 | 109,865 | 89,797 |
| Operating Cash Flow | $-325,593 | $-415,937 | $-298,121 | $-259,413 | $-88,510 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,801 | -89,056 | -66,033 | -41,402 | -16,826 |
| Purchase Sale Intangibles | -3,757 | -3,929 | -4,888 | N/A | N/A |
| Other Investing Activity | -3,757 | -3,929 | -4,888 | 0 | 0 |
| Investing Cash Flow | $-23,558 | $-92,985 | $-70,921 | $-41,402 | $-16,826 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 175,250 | N/A | N/A | N/A |
| Debt Repayment | -351,331 | -98,853 | -45,904 | -15,911 | -20,838 |
| Common Stock Issued | 543 | 248,591 | 179,452 | 180,435 | 180,703 |
| Other Financing Activity | -3,591 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-354,379 | $324,988 | $133,548 | $164,524 | $159,865 |
| Exchange Rate Effect | -8,372 | 4,520 | 257 | -4,453 | 1,312 |
| Beginning Cash Position | 1,348,845 | 1,528,259 | 1,528,259 | 1,528,259 | 1,528,259 |
| End Cash Position | 636,943 | 1,348,845 | 1,293,022 | 1,387,515 | 1,584,100 |
| Net Cash Flow | $-711,902 | $-179,414 | $-235,237 | $-140,744 | $55,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -325,593 | -415,937 | -298,121 | -259,413 | -88,510 |
| Capital Expenditure | -19,801 | -89,056 | -66,033 | -41,402 | -16,826 |
| Free Cash Flow | -345,394 | -504,993 | -364,154 | -300,815 | -105,336 |